BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. ✅
Go to Publication ✅
Glycobiology (Glycobiology ) Vol: 23 Issue 11 Pages: 1281-92 Pub: 2013 Nov Epub: 2013 Sep 7 Authors Yu ZT , Chen C , Newburg DS , |
|
|
Oral supplementation of healthy adults with 2`-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. ✅
The British journal of nutrition (Br J Nutr ) Vol: 116 Issue 8 Pages: 1356-1368 Pub: 2016 Oct Epub: 2016 Oct 10 Authors Elison E , Vigsnaes LK , Rindom Krogsgaard L , Rasmussen J , Sørensen N , McConnell B , Hennet T , Sommer MO , Bytzer P , |
|
|
The Human Milk Oligosaccharide 2`-Fucosyllactose Quenches Campylobacter jejuni-Induced Inflammation in Human Epithelial Cells HEp-2 and HT-29 and in Mouse Intestinal Mucosa. ✅
The Journal of nutrition (J Nutr ) Vol: 146 Issue 10 Pages: 1980-1990 Pub: 2016 Oct Epub: 2016 Sep 14 Authors Yu ZT , Nanthakumar NN , Newburg DS , |
|
|
The Human Milk Oligosaccharide 2`-Fucosyllactose Quenches Campylobacter jejuni-Induced Inflammation in Human Epithelial Cells HEp-2 and HT-29 and in Mouse Intestinal Mucosa. ✅
The Journal of nutrition (J Nutr ) Vol: 146 Issue 10 Pages: 1980-1990 Pub: 2016 Oct Epub: 2016 Sep 14 Authors Yu ZT , Nanthakumar NN , Newburg DS , |
|
|
Development of biosensor-based assays to identify anti-infective oligosaccharides. ✅
Go to Publication ✅
Analytical biochemistry (Anal Biochem ) Vol: 410 Issue 2 Pages: 200-5 Pub: 2011 Mar 15 Epub: 2010 Nov 25 Authors Lane JA , Mehra RK , Carrington SD , Hickey RM , |
|
|
Development of biosensor-based assays to identify anti-infective oligosaccharides. ✅
Go to Publication ✅
Analytical biochemistry (Anal Biochem ) Vol: 410 Issue 2 Pages: 200-5 Pub: 2011 Mar 15 Epub: 2010 Nov 25 Authors Lane JA , Mehra RK , Carrington SD , Hickey RM , |
|
|
Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed. ✅
Go to Publication ✅
Journal of pediatric gastroenterology and nutrition (J Pediatr Gastroenterol Nutr ) Vol: 60 Issue 6 Pages: 825-33 Pub: 2015 Jun Epub: Authors Wang M , Li M , Wu S , Lebrilla CB , Chapkin RS , Ivanov I , Donovan SM , |
|
|
Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed. ✅
Go to Publication ✅
Journal of pediatric gastroenterology and nutrition (J Pediatr Gastroenterol Nutr ) Vol: 60 Issue 6 Pages: 825-33 Pub: 2015 Jun Epub: Authors Wang M , Li M , Wu S , Lebrilla CB , Chapkin RS , Ivanov I , Donovan SM , |
|
|
Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed. ✅
Go to Publication ✅
Journal of pediatric gastroenterology and nutrition (J Pediatr Gastroenterol Nutr ) Vol: 60 Issue 6 Pages: 825-33 Pub: 2015 Jun Epub: Authors Wang M , Li M , Wu S , Lebrilla CB , Chapkin RS , Ivanov I , Donovan SM , |
|
|
Human Milk Oligosaccharides Exhibit Antimicrobial and Antibiofilm Properties against Group B Streptococcus. ✅
Go to Publication ✅
ACS infectious diseases (ACS Infect Dis ) Vol: 3 Issue 8 Pages: 595-605 Pub: 2017 Aug 11 Epub: 2017 Jun 13 Authors Ackerman DL , Doster RS , Weitkamp JH , Aronoff DM , Gaddy JA , Townsend SD , |
|
|
2`-fucosyllactose Supplementation Improves Gut-Brain Signaling and Diet-Induced Obese Phenotype and Changes the Gut Microbiota in High Fat-Fed Mice. ✅
Nutrients (Nutrients ) Vol: 12 Issue 4 Pages: Pub: 2020 Apr 5 Epub: 2020 Apr 5 Authors Lee S , Goodson M , Vang W , Kalanetra K , Barile D , Raybould H , |
|
|
Immunomodulatory and Prebiotic Effects of 2`-Fucosyllactose in Suckling Rats. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 10 Issue Pages: 1773 Pub: 2019 Epub: 2019 Jul 31 Authors Azagra-Boronat I , Massot-Cladera M , Mayneris-Perxachs J , Knipping K , Van`t Land B , Tims S , Stahl B , Garssen J , Franch À , Castell M , Rodríguez-Lagunas MJ , Pérez-Cano FJ , |
|
|
The Protective Effects of 2`-Fucosyllactose against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion. ✅
Nutrients (Nutrients ) Vol: 12 Issue 5 Pages: Pub: 2020 May 1 Epub: 2020 May 1 Authors Wang Y , Zou Y , Wang J , Ma H , Zhang B , Wang S , |
|
|
The Protective Effects of 2`-Fucosyllactose against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion. ✅
Nutrients (Nutrients ) Vol: 12 Issue 5 Pages: Pub: 2020 May 1 Epub: 2020 May 1 Authors Wang Y , Zou Y , Wang J , Ma H , Zhang B , Wang S , |
|
|
Functional proteins in breast milk and their correlation with the development of the infant gut microbiota: a study of mother-infant pairs. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 14 Issue Pages: 1239501 Pub: 2023 Epub: 2023 Sep 13 Authors Xi M , Liang D , Yan Y , Duan S , Leng H , Yang H , Shi X , Na X , Yang Y , Yang C , Szeto IM , Zhao A , |
|
|
2'-Fucosyllactose alleviates OVA-induced food allergy in mice by ameliorating intestinal microecology and regulating the imbalance of Th2/Th1 proportion. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 24 Pages: 10924-10940 Pub: 2023 Dec 11 Epub: 2023 Dec 11 Authors Kou R , Wang J , Li A , Wang Y , Fan D , Zhang B , Fu W , Liu J , Fu H , Wang S , |
|
|
2'-Fucosyllactose alleviates OVA-induced food allergy in mice by ameliorating intestinal microecology and regulating the imbalance of Th2/Th1 proportion. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 24 Pages: 10924-10940 Pub: 2023 Dec 11 Epub: 2023 Dec 11 Authors Kou R , Wang J , Li A , Wang Y , Fan D , Zhang B , Fu W , Liu J , Fu H , Wang S , |
|
|
Human milk oligosaccharides and the association with microbiota in colostrum: a pilot study. ✅
Go to Publication ✅
Archives of microbiology (Arch Microbiol ) Vol: 206 Issue 2 Pages: 58 Pub: 2024 Jan 8 Epub: 2024 Jan 8 Authors Sun W , Tao L , Qian C , Xue P , Tong X , Yang L , Lu F , Wan H , Tao Y , |
|
|
2'-Fucosyllactose Modulates the Intestinal Immune Response to Gut Microbiota and Buffers Experimental Colitis in Mice: An Integrating Investigation of Colonic Proteomics and Gut Microbiota Analysis. ✅
Go to Publication ✅
Food science & nutrition (Food Sci Nutr ) Vol: 13 Issue 6 Pages: e70418 Pub: 2025 Jun Epub: 2025 Jun 10 Authors Dong J , Qian M , Zhou D , Zhu A , Zhang W , |
|
|
Individual and Combined Effects of Medium- and Long-Chain Triacylglycerol and 2'-Fucosyllactose on Small Intestinal Morphology, Barrier Function, and Gut Microbiota in Growing C57BL/6 Mice. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 17 Issue 17 Pages: Pub: 2025 Aug 31 Epub: 2025 Aug 31 Authors Jin X , Shen M , Zhang M , Chen H , Jin Y , Zeng Y , Pan Z , Wang Z , Wang P , Yang Y , Yan Z , Zhu H , Li D , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
